Milnacipran improves pain in fibromyalgia patients: Patient E-diary results over 15 weeks in two randomized, double-blind, placebo-controlled trials

被引：0
|
作者：
Mease, Philip [1 ]
Palmer, Robert H. [2 ]
Qu, Peng [2 ]
Gendreau, R. Michael [3 ]
Zablocki, Rong [3 ]
机构：
[1] Seattle Rheurnatol Associates & Swedish Med Ctr, Seattle, WA USA
[2] Forest Res Inst, Jersey City, NJ USA
[3] Cypress Biosci Inc, San Diego, CA USA
来源：
ARTHRITIS AND RHEUMATISM | 2008年 / 58卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S383 / S383
页数：1
相关论文
共 50 条
  • [1] Milnacipran improves fatigue in patients with fibromyalgia: Results from two randomized, double-blind, placebo-controlled trials
    Clauw, Daniel J.
    Palmer, Robert H.
    Hufford, Michael R.
    Zablocki, Rung
    Wang, Yong
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S383 - S383
  • [2] AN ANALYSIS OF TWO RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIALS ASSESSING THE EFFECT OF MILNACIPRAN FOR FIBROMYALGIA
    Geisser, M. E.
    Palmer, R. H.
    Wang, Y.
    Gendreau, R. M.
    Trifilo, M.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2009, 24 : 19 - 19
  • [3] A Pooled Analysis of Two Randomized, Double-Blind, Placebo-Controlled Trials of Milnacipran Monotherapy in the Treatment of Fibromyalgia
    Geisser, Michael E.
    Palmer, Robert H.
    Gendreau, R. Michael
    Wang, Yong
    Clauw, Daniel J.
    PAIN PRACTICE, 2011, 11 (02) : 120 - 131
  • [4] Effect of Milnacipran on Pain in Fibromyalgia: A European, Double-Blind, Randomized, Placebo-Controlled Trial
    Branco, Jaime C.
    Danneskiold-Samsoe, Bent
    Cherin, Patrick
    Cantagrel, N.
    Vitton, Olivier
    Bunouf, Pierre
    Mainguy, Yves
    ANNALS OF NEUROLOGY, 2009, 66 : S4 - S5
  • [5] Milnacipran for the treatment of fibromyalgia syndrome: A randomized, double-blind, placebo-controlled trial
    Clauw, Daniel J.
    Palmer, Robert H.
    Thacker, Kim
    Gendreau, R. Michael
    Mease, Philip
    NEUROLOGY, 2008, 70 (11) : A162 - A162
  • [6] A double-blind placebo-controlled trial of milnacipran in the treatment of fibromyalgia
    Vitton, O
    Gendreau, M
    Gendreau, J
    Kranzler, J
    Rao, SG
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2004, 19 : S27 - S35
  • [7] Dual Reuptake Inhibitor Milnacipran and Spinal Pain Pathways in Fibromyalgia Patients: A Randomized, Double-Blind, Placebo-Controlled Trial
    Matthey, Alain
    Cedraschi, Christine
    Piguet, Valerie
    Besson, Marie
    Chabert, Jocelyne
    Daali, Youssef
    Courvoisier, Delphine
    Montagne, Agnes
    Dayer, Pierre
    Desmeules, Jules
    PAIN PHYSICIAN, 2013, 16 (05) : E553 - E562
  • [8] Body Weight Changes Associated with Milnacipran Monotherapy in 3 Randomized, Double-Blind, Placebo-Controlled Fibromyalgia Trials
    Arnold, Lesley M.
    Palmer, Robert
    Hufford, Michael R.
    Chen, Wei
    JOURNAL OF WOMENS HEALTH, 2010, 19 (03) : 605 - 605
  • [9] Milnacipran efficacy in the treatment of fibromyalgia syndrome: A 15-week, randomized, double-blind, placebo-controlled trial
    Clauw, Daniel J.
    Palmer, Robert H.
    Thacker, Kim
    Gendreau, R. Michael
    Mease, Philip
    ARTHRITIS AND RHEUMATISM, 2007, 56 (12): : 4231 - 4231
  • [10] Effects of Switching from Duloxetine to Milnacipran: Results from a Randomized, Double-Blind, Placebo-Controlled Study in Fibromyalgia
    Bateman, Lucinda
    Spera, Allan
    Palmer, Robert
    Trugman, Joel
    Thacker, Kimberley
    Lin, Jennifer
    NEUROLOGY, 2012, 78
12345